Effects of Etanercept or Infliximab Treatment on Lipid Profile and Insulin Resistance in Patients With Refractory Rheumatoid Arthritis

Clin Rheumatol. 2007 Oct;26(10):1799-800. doi: 10.1007/s10067-007-0702-2. Epub 2007 Jul 24.

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Atherosclerosis
  • Etanercept
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Infliximab
  • Insulin Resistance*
  • Lipids / chemistry*
  • Prospective Studies
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Rheumatology / methods
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunoglobulin G
  • Lipids
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Etanercept